ArticleJournal for immunotherapy of cancer2020
Correction: Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.